This study investigated whether insulin-like growth factor 1 receptor (IGF1R) single-nucleotide polymorphisms (SNPs) are associated with the development of papillary thyroid cancer (PTC) and their clinicopathologic features in the Korean population. One hundred and five PTC patients and 312 control subjects were enrolled. Two exonic SNPs (rs3743262, Thr766Thr; rs2229765, Glu1043Glu) in IGF1R were genotyped using direct sequencing. SNPStats, SPSS 18.0, and Haploview version 4.2 programs were used to evaluate genetic data. Multiple logistic regression models were used to determine odds ratios (ORs), 95% confidence intervals (CIs), and P values. A SNP (rs2229765) was associated with the development of PTC (OR=0.56, 95% CI=0.35–0.89, P=0.016 in a codominant model 1; OR=0.29, 95% CI=0.11–0.78, P=0.012 in a codominant model 2; OR=0.51, 95% CI=0.32–0.79, P=0.0028 in a dominant model; OR=0.38, 95% CI=0.15–1.01, P=0.031 in a recessive model; OR=0.55, 95% CI=0.38–0.80, P=0.0001 in a log-additive model; OR=1.78, 95% CI=1.25–2.54, P=0.002 in allele distribution). Our data suggest that the IGF1R may be a risk factor of susceptibility in PTC.
Get full access to this article
View all access options for this article.
References
1.
AkulevichNM, SaenkoVA, RogounovitchTI, DrozdVM, LushnikovEF, IvanovVK, MitsutakeN, KominamiR, YamashitaS. 2009. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocr Relat Cancer, 16,2:491–503.
2.
AyturkS, GursoyA, KutA, AnilC, NarA, TutuncuNB. 2009. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol, 161,4:599–605.
3.
Bandurska-StankiewiczE, Aksamit-BialoszewskaE, RutkowskaJ, StankiewiczA, ShafieD. 2011. The effect of nutritional habits and addictions on the incidence of thyroid carcinoma in the Olsztyn province of Poland. Endokrynol Pol, 62,2:145–150.
CharalampousKD, AskewWE. 1977. Cerebellar cAMP levels following acute and chronic morphine administration. Can J Physiol Pharmacol, 55,1:117–120.
6.
ChenAY, JemalA, WardEM. 2009. Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer, 115,16:3801–3807.
7.
de CristofaroT, Di PalmaT, FerraroA, CorradoA, LucciV, FrancoR, FuscoA, ZanniniM. 2011. TAZ/WWTR1 is overexpressed in papillary thyroid carcinoma. Eur J Cancer, 47,6:926–933.
8.
ErdoganM, KaradenizM, OzbekM, OzgenAG, BerdeliA. 2008. Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population. J Endocrinol Invest, 31,9:750–754.
9.
Gamboa-DominguezA, Lino-SilvaS, Candanedo-GonzalezF, Medina-LopezE, Acuna-GonzalezD, Jacinto-CortesI, Gonzalez-TrevinoO. 2011. Trends of thyroid pathology in a referral center: steady prevalence of papillary thyroid carcinoma but goiter increase in thyroidectomies. Rev Invest Clin, 63,2:148–154.
10.
GuoN, YeJJ, LiangSJ, MineoR, LiSL, GianniniS, PlymateSR, SikesRA, Fujita-YamaguchiY. 2003. The role of insulin-like growth factor-II in cancer growth and progression evidenced by the use of ribozymes and prostate cancer progression models. Growth Horm IGF Res, 13,1:44–53.
11.
GursoyA. 2009. Rising thyroid cancer incidence in the world might be related to insulin resistance. Med Hypotheses, 74,1:35–36.
12.
GydeeH, O'NeillJT, PatelA, BauerAJ, TuttleRM, FrancisGL. 2004. Differentiated thyroid carcinomas from children and adolescents express IGF-I and the IGF-I receptor (IGF-I-R). Cancers with the most intense IGF-I-R expression may be more aggressive. Pediatr Res, 55,4:709–715.
13.
HuYP, PatilSB, PanasiewiczM, LiW, HauserJ, HumphreyLE, BrattainMG. 2008. Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor. Cancer Res, 68,19:8004–8013.
14.
IulianoR, PalmieriD, HeH, IervolinoA, BorboneE, PallanteP, CianfloneA, NagyR, AlderH, CalinGA, TrapassoF, GiordanoC, CroceCM, de la ChapelleA, FuscoA. 2010. Role of PTPRJ genotype in papillary thyroid carcinoma risk. Endocr Relat Cancer, 17,4:1001–1006.
15.
LewisCM. 2002. Genetic association studies: design, analysis and interpretation. Brief Bioinform, 3,2:146–153.
MalaguarneraR, FrascaF, GarozzoA, GianiF, PandiniG, VellaV, VigneriR, BelfioreA. 2010. Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. J Clin Endocrinol Metab, 96,3:766–774.
18.
MejiaW, CastroC, UmanaA, de CastroC, RiverosT, Sanchez-GomezM. 2011. Insulin-like growth factor receptor I signaling in a breast cancer cell line. Biomedica, 30,4:551–558.
19.
MilazzoG, GiorginoF, DamanteG, SungC, StampferMR, VigneriR, GoldfineID, BelfioreA. 1992. Insulin receptor expression and function in human breast cancer cell lines. Cancer Res, 52,14:3924–3930.
20.
MosesW, WengJ, KhanafsharE, DuhQY, ClarkOH, KebebewE. 2009. Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation. J Surg Res, 160,2:179–183.
21.
NetaG, BrennerAV, SturgisEM, PfeifferRM, HutchinsonAA, Aschebrook-KilfoyB, YeagerM, XuL, WheelerW, AbendM, RonE, TuckerMA, ChanockSJ, SigurdsonAJ. 2011. Common genetic variants related to genomic integrity and risk of papillary thyroid cancer. Carcinogenesis, 32,8:1231–1237.
22.
PantelyG, MortonM, RahimtoolaSH. 1978. Effects of successful, uncomplicated valve replacement on ventricular hypertrophy, volume, and performance in aortic stenosis and in aortic incompetence. J Thorac Cardiovasc Surg, 75,3:383–391.
23.
ReinmuthN, LiuW, FanF, JungYD, AhmadSA, StoeltzingO, BucanaCD, RadinskyR, EllisLM. 2002. Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer. Clin Cancer Res, 8,10:3259–3269.
24.
RezzonicoJ, RezzonicoM, PusiolE, PitoiaF, NiepomniszczeH. 2008. Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid, 18,4:461–464.
25.
RezzonicoJN, RezzonicoM, PusiolE, PitoiaF, NiepomniszczeH. 2009. Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord, 7,4:375–380.
26.
RotondiM, ErcolinoT, FonteR, LagonigroMS, LeporatiP, VillaniL, La MannaL, MannelliM, ChiovatoL. 2009. Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism. J Endocrinol Invest, 32,2:115–118.
27.
SalajeghehA, SmithRA, KasemK, GopalanV, NassiriMR, WilliamR, LamAK. 2011. Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes. Eur J Surg Oncol, 37,1:93–99.
28.
SchlumbergerM, ChevillardS, OryK, DupuyC, Le GuenB, de VathaireF. 2011. Thyroid cancer following exposure to ionising radiation. Cancer Radiother, 15,5:394–399.
29.
SellC, DumenilG, DeveaudC, MiuraM, CoppolaD, DeAngelisT, RubinR, EfstratiadisA, BasergaR. 1994. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol, 14,6:3604–3612.
30.
ShifrinAL, OgilvieJB, StangMT, FayAM, KuoYH, MatulewiczT, XenachisCZ, VernickJJ. 2010. Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation. Surgery, 148,6:1274–1280discussion 1280–1271.
31.
TangKT, LeeCH. 2010. BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications. J Chin Med Assoc, 73,3:113–128.
32.
ToropainenE, LipponenP, SyrjanenK. 1995. Expression of insulin-like growth factor I (IGF-I) in female breast cancer as related to established prognostic factors and long-term prognosis. Eur J Cancer, 31A,9:1443–1448.
33.
XiongL, KouF, YangY, WuJ. 2007. A novel role for IGF-1R in p53-mediated apoptosis through translational modulation of the p53-Mdm2 feedback loop. J Cell Biol, 78,6:995–1007.
34.
YashiroT, OhbaY, MurakamiH, ObaraT, TsushimaT, FujimotoY, ShizumeK, ItoK. 1989. Expression of insulin-like growth factor receptors in primary human thyroid neoplasms. Acta Endocrinol (Copenh), 121,1:112–120.
